Encompass Health (EHC) analyst forecast and price target
Analyst forecast
Consensus of 15 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $140.00 from $125.00 | Aug 10, 2026 |
| Truist Securities | Maintained | Buy | $150.00 from $140.00 | Aug 7, 2026 |
| UBS | Maintained | Buy | $155.00 from $150.00 | Aug 7, 2026 |
| Barclays | Maintained | Overweight | $144.00 from $140.00 | Aug 6, 2026 |
| TD Cowen | Initiated Coverage | Buy | $125.00 | May 28, 2026 |
| Barclays | Maintained | Overweight | $140.00 from $153.00 | May 5, 2026 |
| Barclays | Maintained | Overweight | $153.00 from $150.00 | Feb 6, 2026 |
| Barclays | Maintained | Overweight | $150.00 from $141.00 | Oct 30, 2025 |
| UBS | Maintained | Buy | $150.00 from $140.00 | Oct 2, 2025 |
| Keybanc | Maintained | Overweight | $140.00 from $135.00 | Sep 16, 2025 |
| B of A Securities | Maintained | Buy | $160.00 from $145.00 | Sep 10, 2025 |
| Truist Securities | Maintained | Buy | $140.00 from $135.00 | Aug 14, 2025 |
| UBS | Maintained | Buy | $140.00 from $130.00 | Aug 6, 2025 |
| Stephens & Co. | Maintained | Overweight | $135.00 | Jun 5, 2025 |
| Keybanc | Maintained | Overweight | $135.00 from $122.00 | May 27, 2025 |
| Truist Securities | Maintained | Buy | $135.00 from $116.00 | Apr 28, 2025 |
| RBC Capital | Maintained | Outperform | $125.00 from $110.00 | Apr 28, 2025 |
| UBS | Maintained | Buy | $130.00 from $117.00 | Apr 28, 2025 |
| Barclays | Maintained | Overweight | $129.00 from $118.00 | Apr 25, 2025 |
| Keybanc | Maintained | Overweight | $122.00 from $120.00 | Apr 25, 2025 |
Frequently asked questions
What is the price target for EHC stock?
The average 12-month analyst price target for Encompass Health (EHC) is $147.25, with a high estimate of $155.00 and a low of $140.00, across 4 analysts.
Is EHC a buy, sell, or hold?
Analysts covering Encompass Health currently average a Buy rating: 15 buy, 0 hold and 0 sell, from 15 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for EHC?
The average price target of $147.25 implies 16.35% upside from the last price of $126.56.
What is the latest analyst rating on EHC?
On Aug 10, 2026, TD Cowen maintained Encompass Health at Buy with a price target of $140.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.